Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Update on single-agent Triapine phase II trials

Feb. 11, 2004

Genasense NDA accepted for review

Feb. 11, 2004

Nippon Kayaku claims a novel antineoplastic antibiotic from Streptomyces sp.

Feb. 11, 2004

Pharmacia scientists report novel telomerase inhibitors in a recent patent

Feb. 11, 2004

Enrollment ceased in phase III NSCLC study of Sarasar

Feb. 10, 2004

Novel steroid sulphate inhibitor for breast tumor therapy reported

Feb. 10, 2004

AP-5346 makes preclinical and clinical progress

Feb. 9, 2004

Alimta approved for use with cisplatin for malignant pleural mesothelioma

Feb. 9, 2004

Orphan drug status for BCX-1777 for T-cell non-Hodgkin's lymphoma

Feb. 9, 2004

DepoCyte launched in Europe

Feb. 9, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 28, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 28, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...